European expert consensus statement on the systemic treatment of alopecia areata
Journal of the European Academy of Dermatology and Venereology · 2024-04 · 38 (4) · 687-694
DOI: 10.1111/jdv.19768 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 02.01.2024. Verfasst von L Rudnicka und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Medical University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Alopecia Areata, Janus Kinase Inhibitors. Die Arbeit wurde bisher 161-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Alopecia areata is an autoimmune form of non‐scarring hair loss. It is usually characterized by limited areas of hair loss. However, the disease may progress to complete scalp and body hair loss (alopecia totalis , alopecia universalis ). In patients with alopecia areata hair loss significantly impacts the quality of life. Children and adolescents with alopecia areata often experience bullying, including physical aggression. The disease severity evaluation tools used in clinical practice are: the Severity of Alopecia Tool (SALT) score and the Alopecia Areata Scale (AAS). A SALT score equal to or greater than 20 constitutes a commonly accepted indication for systemic therapy in alopecia areata. When using the AAS, moderate to severe alopecia areata should be considered a medical indication for systemic treatment. Currently, the only two EMA‐approved medications for alopecia areata are baricitinib (JAK 1/2 inhibitor) for adults and ritlecitinib (JAK 3/TEC inhibitor) for individuals aged 12 and older. Both are EMA‐approved for patients with severe alopecia areata. Other systemic medications used off‐label in alopecia areata include glucocorticosteroids, cyclosporine, methotrexate and azathioprine. Oral minoxidil is considered an adjuvant therapy with limited data confirming its possible efficacy. This consensus statement is to outline a systemic treatment algorithm for alopecia areata, indications for systemic treatment, available therapeutic options, their efficacy and safety, as well as the duration of the therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Medical University of Warsaw, Warsaw, Poland.
- Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Královské Vinohrady University Hospital, Prague, Czech Republic.
- Universitat Internacional de Catalunya, Barcelona, Spain.
- 1st Department of Dermatology-Venereology, Aristotle University Medical School, Thessaloniki, Greece.
- 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, "Attikon" General University Hospital, Athens, Greece.
- Department of Infectious Diseases and Clinical Immunology of the V.N. Karazin Kharkiv National University, Kharkiv, Ukraine.
ORCID-Profile: L Rudnicka, M Arenbergerova, R Grimalt, D Ioannides, A C Katoulis, E Lazaridou, M Olszewska, Y S Ovcharenko, B M Piraccini, A Prohic, A Rakowska, P Reygagne, M A Richard, M Starace, S Vañó-Galvan, A Waskiel-Burnat
Zitieren
APA
Rudnicka, L., Arenbergerova, M., Grimalt, R., Ioannides, D., Katoulis, A. C., Lazaridou, E., Olszewska, M., Ovcharenko, Y. S., Piraccini, B. M., Prohic, A., Rakowska, A., Reygagne, P., Richard, M. A., Soares, R. O., Starace, M., Vañó-Galvan, S., & Waskiel-Burnat, A. (2024). European expert consensus statement on the systemic treatment of alopecia areata. Journal of the European Academy of Dermatology and Venereology, 38(4), 687-694. https://doi.org/10.1111/jdv.19768
Vancouver
Rudnicka L, Arenbergerova M, Grimalt R, Ioannides D, Katoulis AC, Lazaridou E, et al. European expert consensus statement on the systemic treatment of alopecia areata. Journal of the European Academy of Dermatology and Venereology. 2024;38(4):687-694. doi:10.1111/jdv.19768
BibTeX
@article{Rudnicka2024,
author = {Rudnicka, L and Arenbergerova, M and Grimalt, R and Ioannides, D and Katoulis, A C and Lazaridou, E and Olszewska, M and Ovcharenko, Y S and Piraccini, B M and Prohic, A and Rakowska, A and Reygagne, P and Richard, M A and Soares, R O and Starace, M and Vañó-Galvan, S and Waskiel-Burnat, A},
title = {European expert consensus statement on the systemic treatment of alopecia areata},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2024},
volume = {38},
number = {4},
pages = {687--694},
doi = {10.1111/jdv.19768}
}
EUVIMED